Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Antidiabetic and antilipidemic effect of Ilex kaushue S.Y. Hu (Aquifoliaceae) leaves’ extract on streptozotocin-induced diabetic mice

Nguyen Thi Huyen, Nguyen Thi Thuy, Nguyen Thi Nhung, Phan Hong Minh, Bui Thanh Tung.




Abstract
Cited by 0 Articles

Diabetes disease is a worldwide problem. Until now, there is no effective treatment. Traditional medicine uses Ilex kaushue S.Y. Hu (Aquifoliaceae) for supporting the treatment of diabetes and hyperlipidemia. This study was conducted to evaluate the α-glucosidase inhibitory activity and the hypoglycemic and hypolipidemic effect of I. kaushue leaves’ extract. Ilex kaushue leaves were extracted by ethanol 30% with sonication 45 minutes, which was repeated thrice. Ilex kaushue leaves’ extract was used to evaluate the α-glucosidase inhibitory activity in vitro and the hypoglycemic and hypolipidemic effect in vivo on streptozotocin-induced diabetic mice (50 mg/kg b.w. i.p.). Our results show that I. kaushue leaves’ extract had a moderate α-glucosidase inhibitory activity with an IC50 value of 147.25 μg/ml and strong hypoglycemic and hypolipidemic effect on diabetic mice. Our data show that I. kaushue leaves’ extract has the potential antidiabetic and antilipidemic effect.

Key words: Ilex kaushue S. Y. Hu, streptozotocin, diabetes, hypoglycemic, hypolipidemic, α-glucosidase.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.